The market for medical marijuana in North America is huge – and getting bigger. Plenty of companies have sprung up to take advantage. But can you profit from it? Dominic Frisby investigates.
Stocks: the MoneyWeek view
April 2014: A shaky start to 2014 Stocks have had a wobbly start to the year. We remain wary of US stocks, which are expensive. European shares are far better value, and Japan is still a buy. Emerging markets have their problems, but they are increasingly reflected in the price.
• See our view on all the major asset classes here.
Keep your head and invest for the long term, says professional investor Jeremy Whitley. Here, he tips three London-listed stocks to buy now.
Peer-to-peer lending firms are increasingly disrupting traditional banking. John Stepek looks at how to profit from this alternative finance revolution.
The best wood for use in construction is also the most expensive. David Thornton looks at one small-cap that’s come up with a solution.
The newly listed takeaway middleman has a lot of growing to do, says Phil Oakley.
Despite strong share-price growth, this television company is still a buy, says Phil Oakley.
Phil Oakley looks at how the housing market has affected business for Kingfisher, and whether now is the time to buy into the home improvement group.
Fund manager Charles Awdry tips three strong Chinese brands that have a competitive advantage over their foreign rivals.